Marc Carrier
Marc Carrier publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Central Venous Catheters and Hemodialysis.
- World rank
- #90,265 of 7,710,434 ranked researchers
- Rank in Canada
- #2,800 of 183,316
- Works
- 634
- Citations
- 27k
- Citations per work
- 42.5
What does Marc Carrier research?
Marc Carrier's work is mostly in Medicine (67%), Health Professions (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences46072.5%
- Medicine42466.9%
- Health Professions365.6%
- Everything else17427.5%
- 1Internal Medicine27% of their works
- 2Cardiology and Cardiovascular Medicine21% of their works
- 3Surgery9% of their works
- 4Hematology6% of their works
- 5Emergency Medical Services6% of their works
- 6Oncology4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Cardiac tumors and thrombi
- Diagnosis and Treatment of Venous Diseases
- Acute Ischemic Stroke Management
Which keywords describe Marc Carrier's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Clinical Practice Guidelines, Risk Factors, Pulmonary Embolism, Venous Thromboembolism, Anticoagulant Therapy and Atrial Fibrillation.
- Thrombolysis
- Varicose Veins
- PRKAR1A Gene Mutations
- Thrombosis
- Protease-Activated Receptors
- Central Venous Catheterization
- Atrial Fibrillation
- Venous Thromboembolism
- Risk Factors
- Diagnosis
- Antithrombotic Therapy
- Clinical Practice Guidelines
- Pulmonary Embolism
- Anticoagulant Therapy
- Catheter-Related Infections
- Heparin-Induced Thrombocytopenia
- Thrombin
- Cardiac Tumors
- Chronic Venous Insufficiency
- Ischemic Stroke
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antithrombotic Therapy5522 topics
- Diagnosis5522 topics
- Clinical Practice Guidelines5292 topics
- Risk Factors5262 topics
- Pulmonary Embolism4851 topic
- Venous Thromboembolism4851 topic
- Anticoagulant Therapy1751 topic
- Atrial Fibrillation1751 topic
- Catheter-Related Infections1001 topic
- Central Venous Catheterization1001 topic
- Heparin-Induced Thrombocytopenia671 topic
- Protease-Activated Receptors671 topic
- Thrombin671 topic
- Thrombosis671 topic
- Cardiac Tumors541 topic
- PRKAR1A Gene Mutations541 topic
- Chronic Venous Insufficiency441 topic
- Varicose Veins441 topic
- Ischemic Stroke411 topic
- Thrombolysis411 topic
Where does Marc Carrier work?
Marc Carrier's main affiliation in the publication record is Ottawa Hospital, Canada.
How many publications and citations does Marc Carrier have?
OpenAlex counts 634 works and 26,922 citations for Marc Carrier, an h-index of 77, ranking #90,265 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Marc Carrier
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marc Carrier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.